Skip to main content
Clinical Trials/JPRN-UMIN000045299
JPRN-UMIN000045299
Not yet recruiting
未知

Predicting tumor response to neoadjuvant chemotherapy in esophageal cancer patients-correlation between hypoxic imaging and signal transduction pathways - Predicting tumor response to neoadjuvant chemotherapy in esophageal cancer patients-correlation between hypoxic imaging and signal transduction pathways

Institute of Advanced Clinical Medicine, Kindai University0 sites40 target enrollmentNovember 1, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
esophageal cancer
Sponsor
Institute of Advanced Clinical Medicine, Kindai University
Enrollment
40
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 1, 2021
End Date
October 31, 2027
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Institute of Advanced Clinical Medicine, Kindai University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Not received informed consent (2\) Patient age less than 20 years old and more than 80 years old (3\) Non\-squamous cell carcinoma (4\) Patient with synchronous cancer (5\) Patient undergoing endoscopic mucosal resection (6\) Patient undergoing chemoradiotherpy (7\) Pregnant woman, lactating woman, possibility of pregnancy (8\) Patient with serous complication affecting examination (9\) inappropriate patient for this examination justified by attending physician

Outcomes

Primary Outcomes

Not specified

Similar Trials